Issuer · CIK 0002022416
SLXN — Silexion Therapeutics Corp
Recent filings
- Jun 8, 2026·Form 4·Other—
SLXN/Silexion Therapeutics Corp
Shirvan Mitchell · CSO and CDO
Mechanical filing
AI thesis skipped - Jun 8, 2026·Form 4·Other—
SLXN/Silexion Therapeutics Corp
Horenshtein Hadar Mirit · CFO and Secretary
Mechanical filing
AI thesis skipped - Jun 8, 2026·Form 4·Other—
SLXN/Silexion Therapeutics Corp
Hadar Ilan · Chairman and CEO
Mechanical filing
AI thesis skipped - Feb 23, 2026·Form 4·Other—
SLXN/Silexion Therapeutics Corp
Peled Amnon · director
5conviction